BACK
7:00 - 8:30pm EDT
5:00 – 6:30pm MDT
4:00 – 5:30pm PDT
LEARNING OBJECTIVES
At the conclusion of the session, you will be better able to:
Professor (Emeritus), Mayo Clinic
Consultant, Mayo Clinic International
Chair, Atria Academy of Science and Medicine
New York, NY
Monday, June 27th, 2022
7:00 - 8:30pm EDT
5:00 – 6:30pm MDT
4:00 – 5:30pm PDT
LEARNING OBJECTIVES
At the conclusion of the session, you will be better able to:
- Evaluate the potential role of novel agents in migraine prevention
- Highlight recent data on the efficacy and safety of treatments for migraine prevention
- Address key questions around the clinical application of migraine prevention therapy
David W. Dodick, M.D., FAHS
Professor (Emeritus), Mayo Clinic
Consultant, Mayo Clinic International
Chair, Atria Academy of Science and Medicine
New York, NY